+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of acute myeloid leukemia younger adults: the GOELAM experience



Treatment of acute myeloid leukemia younger adults: the GOELAM experience



Annals of Hematology 83 Suppl 1: S104-S105




(PDF emailed within 0-6 h: $19.90)

Accession: 035980797

Download citation: RISBibTeXText

PMID: 15124696

DOI: 10.1007/s00277-004-0850-2


Related references

Treatment of acute myeloblastic leukemia in adults. The GOELAM experience. Hematology & Cell Therapy 38(5): 381-391, 1996

Younger adults with acute myeloid leukemia in remission for ≥ 3 years have a high likelihood of cure: The ECOG experience in over 1200 patients. Leukemia Research 38(8): 901-906, 2014

The role of allogeneic bone marrow transplantation in the younger adults with acute myeloid leukemia in first remission A ten-year experience of the BGMT group. Blood 88(10 SUPPL 1 PART 1-2): 683A, 1996

Quinine given as an MDR reversing agent in the treatment of adult acute myeloid leukemia Results of the randomized GOELAM 2 trial. Blood 96(11 Part 1): 504a-505a, November 16, 2000

Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trial. Leukemia Research 36(9): 1112-1118, 2012

De novo acute myeloid leukemia in adults younger than 60 years of age: socioeconomic aspects and treatment results in a Brazilian university center. Leukemia & Lymphoma 47(8): 1557-1564, 2006

Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group. Leukemia (Basingstoke) 21(3): 453-461, 2007

P-glycoprotein modulation in untreated acute myeloid leukemia Cancer and leukemia group B trials in younger and older adults. Annals of Hematology 83(Supplement 1): S103-S104, 2004

P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adults. Annals of Hematology 83 Suppl 1: S103-S104, 2004

Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study. Journal of Clinical Oncology 23(3): 482-493, 2004

Outcome of Induction and Postremission Therapy in Younger Adults With Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study. Yearbook of Oncology 2006: 174-175, 2006

Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood 127(1): 29-41, 2016

Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols. Medicina Clinica 92(16): 601-604, 1989

Cost-effectiveness analysis of GOELAM SA3, a randomized placebo-controlled protocol of GM-SCF for elderly patients with acute myeloid leukemia. Blood 90(10 SUPPL 1 PART 1): 72A, Nov 15, 1997

Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia. European Journal of Haematology 98(5): 443-449, 2017